vertex News
Most Popular vertex Story
Investors disappointed in Vertex despite strong data
Vertex shares sank on Friday after the company reported that its closely-watched hepatitis C drug telaprevir eradicated the virus in more than 60 percent of patients. Standard therapies on the market... Read more...
Latest Headlines
- August 19, 2008
- August 4, 2008
- June 6, 2008
- March 27, 2008
- November 26, 2007
- November 21, 2007
- November 5, 2007
- July 13, 2007
- December 17, 2006
- December 12, 2006
- November 29, 2006
- July 5, 2006
- June 29, 2006
- March 28, 2006
- February 7, 2006
- December 21, 2005
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
